Back
Crinetics Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
CRNX
Crinetics Pharmaceuticals
Last Price:
$31.12
Seasonality Move:
0.83%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Crinetics Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.92 | Buy |
| 20-day SMA: | 30.64 | Buy |
| 50-day SMA: | 31.08 | Buy |
| 200-day SMA: | 41.17 | Sell |
| 8-day EMA: | 31.87 | Buy |
| 20-day EMA: | 31.23 | Buy |
| 50-day EMA: | 29.95 | Buy |
| 200-day EMA: | 17.47 | Buy |
Crinetics Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.43 | Buy |
| Relative Strength Index (14 RSI): | 60.06 | Buy |
| Chaikin Money Flow: | 635502 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.53 - 32.15) | Buy |
| Bollinger Bands (100): | (29.57 - 34.13) | Buy |
Crinetics Pharmaceuticals Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Crinetics Pharmaceuticals Stock
Is Crinetics Pharmaceuticals Stock a Buy?
-
Crinetics Pharmaceuticals share price is 33.02 while CRNX 8-day simple moving average is 31.92, which is a Buy signal.
-
The stock price of CRNX is 33.02 while Crinetics Pharmaceuticals 20-day SMA is 30.64, which makes it a Buy.
-
Crinetics Pharmaceuticals 50-day simple moving average is 31.08 while CRNX share price is 33.02, making it a Buy technically.
-
CRNX stock price is 33.02 and Crinetics Pharmaceuticals 200-day simple moving average is 41.17, creating a Sell signal.
CRNX Technical Analysis vs Fundamental Analysis
Sell
28
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy or a Sell?
-
Crinetics Pharmaceuticals stock is rated a SellThe current Crinetics Pharmaceuticals [CRNX] share price is $33.02. The Score for CRNX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Crinetics Pharmaceuticals Stock Info
Market Cap:
3.1B
Price in USD:
33.02
Share Volume:
976.2K
Crinetics Pharmaceuticals 52-Week Range
52-Week High:
62.53
52-Week Low:
24.10
Sell
28
Crinetics Pharmaceuticals (CRNX)
is a Sell
Crinetics Pharmaceuticals Share Price Forecast
-
What is the Crinetics Pharmaceuticals stock price today?The Crinetics Pharmaceuticals stock price is 33.02 USD today.
-
Will CRNX stock go up or go down?Crinetics Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Crinetics Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Crinetics Pharmaceuticals is overvalued.
Is Crinetics Pharmaceuticals Stock a Buy?
-
Crinetics Pharmaceuticals share price is 33.02 while CRNX 8-day exponential moving average is 31.87, which is a Buy signal.
-
The stock price of CRNX is 33.02 while Crinetics Pharmaceuticals 20-day EMA is 31.23, which makes it a Buy.
-
Crinetics Pharmaceuticals 50-day exponential moving average is 29.95 while CRNX share price is 33.02, making it a Buy technically.
-
CRNX stock price is 33.02 and Crinetics Pharmaceuticals 200-day simple moving average is 17.47, creating a Buy signal.
Fundamental Analysis of Crinetics Pharmaceuticals
Is Crinetics Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.11 per share.
Technical Analysis of Crinetics Pharmaceuticals
Should I short Crinetics Pharmaceuticals stock?
-
CRNX Moving Average Covergence Divergence (MACD) indicator is 0.43, suggesting Crinetics Pharmaceuticals is a Buy
-
Crinetics Pharmaceuticals Relative Strength Index (RSI) is 60.06, which suggest Crinetics Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Crinetics Pharmaceuticals is (29.53 - 32.15), which suggest Crinetics Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Crinetics Pharmaceuticals is (29.57 - 34.13), which suggest Crinetics Pharmaceuticals is a Buy
* Crinetics Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.